Background
Over the last several years there has been a dramatic increase in the level of interest from both professional and lay communities concerning research employing primary human stem cells. Stem cells exhibit, to varying degrees, two defining features: the ability to divide and thus produce more stem cells almost indefinitely (termed self renewal), and the potential to become many different kinds of tissue, e.g. nerve, muscle or blood etc. (termed multipotency). Stem cells can be isolated from various sources including bone marrow, blood and certain tumors however most research has focused on arguably the most useful type of stem cell – termed embryonic stem (ES) cells. Primary ES cells can be isolated from a microscopic ball of cells that form a few days after eggs are fertilized. Many groups have been able to isolate and propagate these stem cells in culture and produce continuous ES-derived cell lines that retain many of the functional properties of primary ES cells. |
GE Healthcare Position
|
Questions and Answers
Is GE carrying out work on established stem cell lines? What is an established ES cell line and how do they differ from primary ES cells? Why are ES lines so important?
stem cell line. 2) They can be grown continually and in large numbers in artificial culture. Why is GE interested in stem cells? Where would GE obtain established ES cell lines? Is GE Healthcare carrying out ES cell research in the US for legal reasons? Does GE work on human embryo or fetus-derived material? How does GE dispose of unwanted cells? |
